If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
335.00    -2.20 (-0.65%)
Bid:
335.90
Ask:
336.00
Spread: 0.10 (0.03%)
Market Cap: £7.35b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Directorate Changes

12 Mar 2021 09:00

RNS Number : 9998R
Sainsbury(J) PLC
12 March 2021
 

12 March 2021

J Sainsbury plc - Directorate Changes

Appointment of Adrian Hennah as Non-Executive Director and Chair of Audit Committee

J Sainsbury plc today announces that Adrian Hennah will join the Board as a Non-Executive Director. Adrian will join the Audit Committee and Nomination Committee on 1 April 2021 and will take over as Chair of the Audit Committee following the AGM.

Adrian will replace David Keens, who is not seeking re-election to the Board at the July 2021 AGM after six years of service.

Commenting on the appointment, Martin Scicluna, Chairman of Sainsbury's, said:

"I am delighted to welcome Adrian as a Non-Executive Director and Chair of the Audit Committee. As a highly accomplished CFO of three FTSE100 companies spanning 18 years, he has significant and varied expertise. Additionally, Adrian was a Non-Executive Director and Audit Committee Chair of another FTSE100 company for nine years and I am confident he will bring fresh thinking to our Board as we deliver against our plan.

"I would like to thank David Keens for his six years of service. He has been a thoughtful and influential voice on the Board and we are grateful for his significant contribution."

Adrian Hennah said:

"I am very pleased to be joining Sainsbury's and look forward to bringing my experience to the Board. I am familiar with the business through previous roles and have always been impressed by the company's values and commitment to do the right thing for its customers. It is an exciting time to be involved in food retail and I am looking forward to getting started."

Adrian spent 18 years in Chief Financial Officer (CFO) roles at three FTSE 100 companies. He was CFO at RB for seven years and held the same position at Smith & Nephew and Invensys. Prior to this he spent 18 years at GSK working in both finance and operations. Adrian began his career at PWC.

Adrian was previously Non-Executive Director and Chair of the Audit Committee at RELX. He stepped down from the Board last year having completed nine years of service. No further information is required to be disclosed under 9.6.13R of the UK Listing Rules.

 

Ends

Enquiries:

Investor Relations Media Relations

James Collins +44 (0) 20 7695 0080 Rebecca Reilly +44 (0) 20 7695 7295

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZFLFFFXLEBBF
Date   Source Headline
20th Apr 20183:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20183:45 pmRNSTotal Voting Rights
27th Mar 201810:00 amRNSStore Visit
23rd Mar 20183:00 pmRNSDirector/PDMR Shareholding
1st Mar 20183:00 pmRNSTotal Voting Rights
23rd Feb 20183:00 pmRNSDirector/PDMR Shareholding
6th Feb 201810:15 amRNSHolding(s) in Company
5th Feb 20183:45 pmRNSDirector/PDMR Shareholding
1st Feb 20183:45 pmRNSTotal Voting Rights
1st Feb 20183:45 pmRNSBlock listing Interim Review
1st Feb 201811:07 amRNSAcquisition of Nectar from Aimia Inc
31st Jan 201810:15 amRNSHolding(s) in Company
26th Jan 20184:00 pmRNSDirector/PDMR Shareholding
10th Jan 20187:00 amRNSThird Quarter Trading Statement
2nd Jan 20183:45 pmRNSTotal Voting Rights
29th Dec 201711:00 amRNSDirector/PDMR Shareholding
1st Dec 20173:15 pmRNSTotal Voting Rights
1st Dec 20173:15 pmRNSDirector/PDMR Shareholding
16th Nov 201711:30 amRNSPerpetual Subordinated Convertible Bond Adjustment
16th Nov 201711:30 amRNSConvertible Bond Adjustment
9th Nov 20177:00 amRNSHalf-year Report
3rd Nov 20172:30 pmRNSDirector/PDMR Shareholding
1st Nov 20174:00 pmRNSTotal Voting Rights
6th Oct 20172:25 pmRNSDirector/PDMR Shareholding
2nd Oct 20171:00 pmRNSTotal Voting Rights
27th Sep 20174:43 pmRNSDirectorate Change
11th Sep 20177:00 amRNSDirectorate Change
5th Sep 20173:28 pmRNSDirector/PDMR Shareholding
1st Sep 201710:03 amRNSTotal Voting Rights
10th Aug 20174:10 pmRNSDirector/PDMR Shareholding
1st Aug 20172:17 pmRNSBlock listing Interim Review
1st Aug 20171:45 pmRNSTotal Voting Rights
14th Jul 201711:30 amRNSDirector Declaration
13th Jul 20173:15 pmRNSDirector/PDMR Shareholding
11th Jul 20172:00 pmRNSDirector/PDMR Shareholding
11th Jul 20179:48 amRNSDirector/PDMR Shareholding
5th Jul 20175:10 pmRNSResult of AGM
5th Jul 20174:58 pmRNSHolding(s) in Company
4th Jul 20177:00 amRNSFirst Quarter Trading Statement
3rd Jul 20173:14 pmRNSTotal Voting Rights
15th Jun 20174:14 pmRNSDirector/PDMR Shareholding
2nd Jun 20171:25 pmRNSAnnual Report and Notice of AGM 2017
1st Jun 20172:45 pmRNSTotal Voting Rights
18th May 20173:33 pmRNSDirector/PDMR Shareholding
17th May 20173:50 pmRNSHolding(s) in Company
12th May 20173:30 pmRNSDirector/PDMR Shareholding
12th May 201710:15 amRNSDirector/PDMR Shareholding
11th May 20173:30 pmRNSConvertible Bonds Adjustment
11th May 20173:30 pmRNSPerpetual Subordinated Convertible Bond Adjustment
8th May 20171:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.